Advisory Committee on Immunization Practices: Teleconference, 28704 [E6-7555]
Download as PDF
<![CDATA[
28704
Federal Register / Vol. 71, No. 95 / Wednesday, May 17, 2006 / Notices
as barriers to the provision of effective
care coordination for individuals with
spina bifida, CDC’s National Center on
Birth Defects and Developmental
Disabilities proposes to conduct a study
using focus groups and interviews. The
proposed activity is part of the National
Spina Bifida Program mandated in
Section 317C of the Public Health
Service Act (42 U.S.C. 247b–4)
coordination for individuals with spina
bifida including how care is coordinated
in the clinic, barriers and facilitators to
the provision of care coordination, the
effectiveness of care coordination, and
recommendations for improving care
coordination. All responses to the focus
groups and interviews will be treated in
a private manner.
There will be no costs to the
respondents other than their time.
Researchers will visit 10 spina bifida
clinics nationwide. At each clinic, 1
focus group with approximately 8
caregivers of children with spina bifida
will be conducted. Each focus group
will last about 2 hours. At each clinic,
approximately 5 clinical staff will be
interviewed; each interview will take
approximately 45 minutes. Focus group
and interview respondents will be asked
a variety of questions related to care
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
reponses per
respondent
Number of
respondents
Respondents
Average
burden per
response
Total burden
hours
Caregiver screener ..........................................................................................
Caregiver focus group .....................................................................................
Clinic staff telephone screener ........................................................................
Clinic staff interview .........................................................................................
100
80
55
50
1
1
1
1
15/60
2
10/60
45/60
25
160
9
38
Total ..........................................................................................................
........................
........................
........................
232
Dated: May 10, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–7482 Filed 5–16–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices: Teleconference
mstockstill on PROD1PC61 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following Federal Committee
meeting.
Name: Advisory Committee on
Immunization Practices (ACIP).
Time and Date: 10 a.m.–11 a.m., May 17,
2006.
Place: The conference call will originate at
the National Immunization Program (NIP), in
Atlanta, Georgia. Please see SUPPLEMENTARY
INFORMATION for details on accessing the
conference call.
Status: Open to the public, limited only by
the availability of telephone ports.
Purpose: The Committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
Committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
VerDate Aug<31>2005
15:08 May 16, 2006
Jkt 208001
Matters To Be Discussed: To discuss the
absence of an official 2-dose recommendation
for mumps vaccine.
Supplementary Information: This
conference call is scheduled to begin at 10
a.m., Eastern Standard Time. To participate
in the conference call, please dial 1–800–
857–5009 and reference passcode 9393375.
As provided under 41 CFR 102–3.150(b),
the public health urgency of this agency
business requires that the meeting be held
prior to the first available date for publication
of this notice in the Federal Register.
For Further Information Contact: Demetria
Gardner, Epidemiology and Surveillance
Division, National Immunization Program,
CDC, 1600 Clifton Road, NE, E–05, Atlanta,
Georgia 30333, telephone 404/639–8836, fax
404/639–8616.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and ATSDR.
Dated: May 12, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E6–7555 Filed 5–16–06; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[AK–930–5420–FR–L030; AA–85443, AA–
85444, AA–85445, AA–85447]
Notice of Applications for Recordable
Disclaimers of Interest for Lands
Underlying Chilkat Lake, Chilkat River,
Tsirku River, and Klehini River in
Southeast Alaska
Bureau of Land Management,
Interior.
ACTION: Notice.
AGENCY:
SUMMARY: The State of Alaska has filed
applications for recordable disclaimers
of interest in certain lands underlying
Chilkat Lake, Chilkat River, Tsirku
River, and Klehini River in Southeast
Alaska by the United States.
DATES: Comments on the State of
Alaska’s applications should be
submitted on or before August 15, 2006.
Comments on the BLM Draft
Navigability Report should be submitted
on or before July 17, 2006.
ADDRESSES: Comments should be sent to
the Chief, Branch of Lands and Realty,
BLM Alaska State Office, 222 West 7th
Avenue #13, Anchorage, Alaska 99513–
7599.
FOR FURTHER INFORMATION CONTACT:
Callie Webber at 907–271–3167 or you
may visit the BLM recordable disclaimer
of interest Web site at https://
www.ak.blm.gov.
On May
12, 2004, the State of Alaska (State) filed
applications for recordable disclaimers
of interest pursuant to Section 315 of
the Federal Land Policy and
SUPPLEMENTARY INFORMATION:
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\17MYN1.SGM
17MYN1
]]>Agencies
[Federal Register Volume 71, Number 95 (Wednesday, May 17, 2006)]
[Notices]
[Page 28704]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7555]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices: Teleconference
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following Federal Committee meeting.
Name: Advisory Committee on Immunization Practices (ACIP).
Time and Date: 10 a.m.-11 a.m., May 17, 2006.
Place: The conference call will originate at the National
Immunization Program (NIP), in Atlanta, Georgia. Please see
Supplementary Information for details on accessing the conference
call.
Status: Open to the public, limited only by the availability of
telephone ports.
Purpose: The Committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines.
Matters To Be Discussed: To discuss the absence of an official
2-dose recommendation for mumps vaccine.
Supplementary Information: This conference call is scheduled to
begin at 10 a.m., Eastern Standard Time. To participate in the
conference call, please dial 1-800-857-5009 and reference passcode
9393375.
As provided under 41 CFR 102-3.150(b), the public health urgency
of this agency business requires that the meeting be held prior to
the first available date for publication of this notice in the
Federal Register.
For Further Information Contact: Demetria Gardner, Epidemiology
and Surveillance Division, National Immunization Program, CDC, 1600
Clifton Road, NE, E-05, Atlanta, Georgia 30333, telephone 404/639-
8836, fax 404/639-8616.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the CDC and ATSDR.
Dated: May 12, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC). 4
[FR Doc. E6-7555 Filed 5-16-06; 8:45 am]
BILLING CODE 4163-18-P
